Literature DB >> 9860805

Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications.

W Danysz1, C G Parsons.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9860805

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  132 in total

1.  Characterization of the binding of two novel glycine site antagonists to cloned NMDA receptors: evidence for two pharmacological classes of antagonists.

Authors:  B Chopra; P L Chazot; F A Stephenson
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Selective mGluR1 antagonist EMQMCM inhibits the kainate-induced excitotoxicity in primary neuronal cultures and in the rat hippocampus.

Authors:  Maria Śmiałowska; Krystyna Gołembiowska; Małgorzata Kajta; Barbara Zięba; Anna Dziubina; Helena Domin
Journal:  Neurotox Res       Date:  2011-12-06       Impact factor: 3.911

3.  The ability of new non-competitive glutamate receptor blockers to weaken motor disorders in animals.

Authors:  N I Rukoyatkina; L V Gorbunova; V E Gmiro; N Ya Lukomskaya
Journal:  Neurosci Behav Physiol       Date:  2003-03

4.  Involvement of NMDA receptor in the modulation of excitatory and inhibitory amino acid neurotransmitters release in cortical neurons.

Authors:  E López; J Hernandez; C Arce; S Cañadas; M J Oset-Gasque; M P González
Journal:  Neurochem Res       Date:  2010-06-12       Impact factor: 3.996

5.  Stacking interaction and its role in kynurenic acid binding to glutamate ionotropic receptors.

Authors:  Alexander V Zhuravlev; Gennady A Zakharov; Boris F Shchegolev; Elena V Savvateeva-Popova
Journal:  J Mol Model       Date:  2011-08-12       Impact factor: 1.810

6.  Alterations in brain extracellular dopamine and glycine levels following combined administration of the glycine transporter type-1 inhibitor Org-24461 and risperidone.

Authors:  Katalin Nagy; Bernadett Marko; Gabriella Zsilla; Peter Matyus; Katalin Pallagi; Geza Szabo; Zsolt Juranyi; Jozsef Barkoczy; Gyorgy Levay; Laszlo G Harsing
Journal:  Neurochem Res       Date:  2010-08-20       Impact factor: 3.996

Review 7.  Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

8.  NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats.

Authors:  Ian A Mendez; Keith A Trujillo
Journal:  Psychopharmacology (Berl)       Date:  2007-11-10       Impact factor: 4.530

9.  Antinociceptive effect of intracerebroventricular administration of D-serine on formalin-induced pain.

Authors:  Miho Ito; Masanobu Yoshikawa; Kenji Ito; Mitsumasa Matsuda; Xing Lu Jin; Shigeru Takahashi; Hiroyuki Kobayashi; Toshiyasu Suzuki
Journal:  J Anesth       Date:  2013-09-19       Impact factor: 2.078

10.  Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia.

Authors:  Tatiana Lipina; Viviane Labrie; Ina Weiner; John Roder
Journal:  Psychopharmacology (Berl)       Date:  2005-03-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.